Inhalation Drug Dispensing Fee Likely To Decrease In 2006, CMS Says
Executive Summary
CMS expects the dispensing fee for Part B inhalation drugs administered with a nebulizer to drop in 2006 and is soliciting comments on what the new level should be, according to its proposed Medicare FDL-1Physician Fee Schedule for 2006
You may also be interested in...
Epogen Part B Payments To Be Based On ASP In All Dialysis Centers – CMS
Medicare will reimburse Amgen's Epogen (epoetin alfa) at the average sales price plus 6% in freestanding and hospital-based dialysis facilities in 2006 under the proposed FDL-1Physician Fee Schedule for 2006, announced Aug. 1
Inhalation Drugs Will Have $57 “Transitional” Dispensing Fee In 2005
The Centers for Medicare & Medicaid Services is increasing the dispensing fee for inhalation drugs delivered via nebulizers by over 1,000% as a means of managing the transition of the inhalation therapy market during 2005
CMS Endorses Increased Dispensing Fees For Inhalation Drugs
The Centers for Medicare & Medicaid Services believes that $55 to $64 per month is an appropriate range for inhalation therapy dispensing fees in 2005